| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 07/14/1999 | EP0928331A1 Biologically active fragment of bacillus stearothermophilus dna polymerase |
| 07/14/1999 | EP0928330A1 MATERIALS AND METHODS FOR DETECTION OF $i(OXALOBACTER) |
| 07/14/1999 | EP0784698A4 Biological resolution of racemic indene oxide to (1s,2r)-indene oxide |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/14/1999 | EP0287653B1 Hormone receptor compositions and methods |
| 07/14/1999 | CN1222936A Recombinant protein containing c-terminal fragment of plasmodium MSP-1 |
| 07/14/1999 | CN1044133C Process for preparing nucleotide series corresponding to human erythropoietin gene fragment |
| 07/13/1999 | US5922927 Methods for producing tetracycline-regulated transgenic mice |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922583 Bacterial cell chromosome is irreversibly modified to effect production of a first substance toxic to bacterial cell, wherein the recombinant plasmid includes a genetic material which produces a second substance neutralizes the toxicity |
| 07/13/1999 | US5922582 Indole alkaloid type compound 0089-D |
| 07/13/1999 | US5922581 Process for the production of d-biotin |
| 07/13/1999 | US5922580 Contacting a reducing partial starch hydrolysate with a novel enzyme which forms a non-reducing saccharide in the absence of trehalose; glucoamylase and glycosidase yield trehalose when allowed to act on the non-reducing saccharide |
| 07/13/1999 | US5922578 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide |
| 07/13/1999 | US5922569 Process for the production of polypeptides |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922560 Astaxanthin over-producing strains of Phaffia rhodozyma, methods for their cultivation, and their use in animal feeds |
| 07/13/1999 | US5922549 Process for screening substances having a modulating effect on an interleukin-5 receptor mediated cellular signal transmission pathway |
| 07/13/1999 | US5922541 Method for detection of PF4A receptor nucleic acid |
| 07/13/1999 | US5922329 Immunity against giardia from vaccine from isolation of exotoxin |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922321 Prostate-specific kallikrein |
| 07/13/1999 | CA2015828C Canine corona virus vaccine |
| 07/13/1999 | CA1340650C Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same |
| 07/13/1999 | CA1340643C Thermally stable and ph stable subtilisin analogs and method for production thereof |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/12/1999 | CA2256757A1 Method of producing l-serine by fermentation |
| 07/08/1999 | WO1999033997A1 Luciferase and method for assaying intracellular atp by using the same |
| 07/08/1999 | WO1999033993A1 Promoter from ashbya gossypii |
| 07/08/1999 | WO1999033988A1 A process for preparing human proinsulin |
| 07/08/1999 | WO1999033975A1 Heat shock transcription factor-binding protein |
| 07/08/1999 | WO1999033876A1 Novel seven-pass transmembrane receptor protein |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | CA2315750A1 A process for preparing human proinsulin |
| 07/08/1999 | CA2315534A1 Promoter from ashbya gossypii |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927761A2 Purinebiosynthesis genes from Ashbya possypii and use for the microbial Riboflavinsynthesis |
| 07/07/1999 | EP0927760A2 Immunreactive parts of the glycoproteins gpII from Varicell-Zoster-Virus |
| 07/07/1999 | EP0927759A2 Immunoreactive protein VP26 of Varicella Zoster Virus (VZV) and its diagnostic use |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927755A2 Haloaccloacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme |
| 07/07/1999 | EP0927260A1 In vivo protein synthesis method |
| 07/07/1999 | EP0927259A1 MODIFIED alpha-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
| 07/07/1999 | EP0927246A2 Adenylosuccinate synthetase |
| 07/07/1999 | EP0637336B1 Mn gene and protein |
| 07/07/1999 | EP0578712B1 Novel proteases |
| 07/07/1999 | EP0528970B1 Methods and compositions for modulating ethylene levels in plant tissues |
| 07/07/1999 | EP0502188B1 Cloned glutamic acid decarboxylase |
| 07/07/1999 | CN1221880A In vitro method for determining presence of hepatocellular carcindoma |
| 07/07/1999 | CN1221879A In vitro method for determining presence of hepatocellular carcindoma |
| 07/07/1999 | CN1221752A Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 07/07/1999 | CN1044005C Process for prodn. of amide compounds and microorganisms for use therein |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919899 Wound healing agents for burns, injuries, and surgeries; antiulcer agents; antiinflammatory agents; markers in diagnosis of tumors |
| 07/06/1999 | US5919895 Secretion of hirudin derivatives |
| 07/06/1999 | US5919693 Nucleic acid sequences of heparinases ii and iii, and transformed cells expressing heparinase ii and iii; degrade heparin and heparin sulfate |
| 07/06/1999 | US5919692 Ubiquitous ATP-sensitive potassium-channel genes |
| 07/06/1999 | US5919691 Enzyme and enzyme preparation with endoglucanase activity |
| 07/06/1999 | US5919690 Dna sequence encoding a polypeptide derived from a strain of aspergillus having alpha-galactosidase activity which is not inhibited by galactose; host cells transformed for efficient biosynthesis of the galactosidase |
| 07/06/1999 | US5919672 Adding racemic lactam to microorganism media containing buffer and solvent or enzyme with solvent and buffer to obtain an isomer, hydrolyzing the carboxylic ester of the compound to form an acid |
| 07/06/1999 | US5919670 Process for producing L-amino acids by fermentation |
| 07/06/1999 | US5919669 Process for preparing L-tertiary-leucine and L-phosphinothricine by transamination |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919662 Producing biotin and/or desthiobiotin at high yield by culturing to high density escherichia coli strain containing recombinant plasmid with biotin operon; less growth inhibition by build-up of acetate in media |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919651 Expression of polypeptides in yeast |
| 07/06/1999 | US5919648 One step conversion of cephalosporin c or derivative into 7-aminocephalosporanic acid or derivative using aminohydrolase from psuedomonas vesicularis b965; for cephalothin, cephaloridine, and cefuroxime synthesis |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | US5919636 Genetic engineered human embryonic kidney cells containing mammmalian scavenger gene |
| 07/06/1999 | US5919619 Preferentally suppressing gene expression of target proteins by synthesizing and then hybridizing complementary oligonucleotide to subsequence of specific messenger ribonucleic acid in cell |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919447 Strain of bacillus for controlling plant disease |
| 07/06/1999 | US5919272 Process for providing localized variation in the color density of fabrics |
| 07/06/1999 | US5918747 Process for recovering polyhydroxyalkanoates using centrifugal fractionation |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA2086417C Melanin production by transformed organisms |
| 07/06/1999 | CA2079367C Process for production of omega 9 type polyunsaturated fatty acid |
| 07/06/1999 | CA2004764C Ancrod proteins, their preparation and use |
| 07/06/1999 | CA1340629C T-cell receptor gene located within alpha locus and dna constructions |
| 07/06/1999 | CA1340627C T4 glycoprotien fragments and use of fragments of t4 in the treatment of aids |
| 07/06/1999 | CA1340625C Cloned cardionatrin cdna |
| 07/06/1999 | CA1340624C Modified vaccinia virus and methods for making and using the same |
| 07/01/1999 | WO1999032653A1 Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugates vaccines |
| 07/01/1999 | WO1999032646A1 Equine infectious anaemia virus (eiav) based |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032617A2 Expression cloning in filamentous fungi |
| 07/01/1999 | WO1999032608A1 MULTIPLE DRUG RESISTANCE GENE atrD OF $i(ASPERGILLUS NIDULANS) |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999020771A3 Multiply-substituted protease variants with altered net charge for use in detergents |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315269A1 Equine infectious anaemia virus (eiav) based |